College of Medicine faculty receive biomedical artificial intelligence grants

Penn State College of Medicine has awarded $225,000 in pilot funding to researchers as part of its strategic plan to apply artificial intelligence and informatics to advance biomedical research and address health challenges. Nine investigators received seed funding for projects that aim to use cutting-edge technology and computational innovation to develop new therapeutics, diagnostics, and preventive strategies.

psu.edu

Relevant topic timeline:

8/21/2023

A16z-Backed AI Biotech Startup Genesis Therapeutics Raises $200M

California-based startup Genesis Therapeutics has raised $200 million in Series B funding, led by Andreessen Horowitz Bio + Health and an unnamed US-based life-sciences-focused investor, to further develop its AI platform for small-molecule drug discovery and expand its pipeline.

8/29/2023

The company landscape for artificial intelligence in large-molecule drug discovery

Artificial intelligence (AI) techniques, particularly machine learning, are increasingly being used in drug research and development (R&D), with applications expanding beyond small molecules to include large-molecule modalities such as antibodies, gene therapies, and RNA-based therapies. These therapies, which make up a significant portion of the biopharma industry's current and future commercial potential, are expected to represent approximately 50% of the oncology market by revenue in 2030, with the majority coming from antibodies.

9/7/2023

AI Drug Discovery Startup Noetik Raises $14M to Develop Precision Immunotherapies for Cancer Using Machine Learning

Noetik, an AI drug discovery company, has raised $14 million in seed funding to support its development of precision therapeutics in immuno-oncology using machine learning and human data. The funding will be used to expand Noetik's team and continue the development of transformer-based machine learning methods.

9/11/2023

Cornell Awarded $1.7 Million to Launch AI-Powered Precision Nutrition Program

Cornell University has received a $1.7 million grant from the NIH to develop the Artificial Intelligence and Precision Nutrition Training Program, which aims to train scientists in AI and machine learning to address complex health challenges related to nutrition and chronic diseases.

9/18/2023

Feinstein Institutes Awarded $3.1M to Develop AI Tools for Hospital Patient Risk Monitoring

Scientists at The Feinstein Institutes for Medical Research have been awarded $3.1 million to develop artificial intelligence and machine learning tools to monitor hospitalized patients and predict deterioration, aiming to improve patient outcomes.

9/20/2023

Zuckerberg's Chan Zuckerberg Initiative Building Massive AI Computing Cluster to Advance Biomedical Research

The Chan Zuckerberg Initiative plans to build a large GPU cluster to apply AI to biomedical research in order to understand disease at a cellular level and help develop treatments, using computational models to simulate and predict cellular function.

9/22/2023

AI Speeds Up Patient Recruitment and Reduces Costs of Clinical Drug Trials

Major drugmakers are using artificial intelligence (AI) to accelerate drug development by quickly finding patients for clinical trials and reducing the number of participants needed, potentially saving millions of dollars. AI is increasingly playing a substantial role in human drug trials, with companies such as Amgen, Bayer, and Novartis using AI tools to scan vast amounts of medical data and identify suitable trial patients, significantly reducing the time and cost of recruitment. The use of AI in drug development is on the rise, with the US FDA receiving over 300 applications that incorporate AI or machine learning in drug development from 2016 through 2022.

Topics

Posted 8/25/2023, 6:49:35 PM